COST NO FEE
BOSTON MEDICAL CENTER CORPORATION - 75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183
PIID: 75N94023F00001
Signed Date: Nov 26, 2025Effective Date: Sep 28, 2023End Date: Closed on Feb 28, 2026
Key Details
Description
75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.